{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:21:38Z","timestamp":1738214498278,"version":"3.34.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K11759","19K07139"],"award-info":[{"award-number":["22K11759","19K07139"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Joint Research Program of Juntendo University, Faculty of Health and Sports Science"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07122-5","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T02:28:27Z","timestamp":1738117707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ester derivatives of Dictyostelium differentiation-inducing factors exhibit antibacterial activity, possibly via a prodrug-like function"],"prefix":"10.1186","volume":"18","author":[{"given":"Katsunori","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhisa","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzuru","family":"Kubohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"7122_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ja.2005.1","volume":"58","author":"J B\u00e9rdy","year":"2005","unstructured":"B\u00e9rdy J. Bioactive microbial metabolites. J Antibiot. 2005;58:1\u201326.","journal-title":"J Antibiot"},{"key":"7122_CR2","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1038\/nbt1206-1497","volume":"24","author":"P Fernandes","year":"2006","unstructured":"Fernandes P. Antibacterial discovery and development\u2013the failure of success? Nat Biotechnol. 2006;24:1497\u2013503.","journal-title":"Nat Biotechnol"},{"key":"7122_CR3","first-page":"237","volume":"398","author":"KI Mohr","year":"2016","unstructured":"Mohr KI. History of antibiotics research. Curr Top Microbiol Immunol. 2016;398:237\u201372.","journal-title":"Curr Top Microbiol Immunol"},{"key":"7122_CR4","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1039\/C7NP00026J","volume":"34","author":"O Genilloud","year":"2017","unstructured":"Genilloud O. Actinomycetes: still a source of novel antibiotics. Nat Prod Rep. 2017;34:1203\u201332.","journal-title":"Nat Prod Rep"},{"key":"7122_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ijantimicag.2018.11.010","volume":"53","author":"GA Durand","year":"2019","unstructured":"Durand GA, Raoult D, Dubourg G. Antibiotic discovery: history, methods and perspectives. Int J Antimicrob Agents. 2019;53:371\u201382.","journal-title":"Int J Antimicrob Agents"},{"key":"7122_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","volume":"51","author":"MI Hutchings","year":"2019","unstructured":"Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol. 2019;51:72\u201380.","journal-title":"Curr Opin Microbiol"},{"key":"7122_CR7","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/antibiotics12081250","volume":"12","author":"J Correia","year":"2023","unstructured":"Correia J, Borges A, Sim\u00f5es M, Sim\u00f5es LC. Beyond Penicillin: the potential of filamentous fungi for drug discovery in the age of antibiotic resistance. Antibiotics. 2023;12:1250.","journal-title":"Antibiotics"},{"key":"7122_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1128\/AAC.35.4.776","volume":"35","author":"DM Shlaes","year":"1991","unstructured":"Shlaes DM, Etter L, Gutmann L. Synergistic killing of vancomycin-resistant enterococci of classes A, B, and C by combinations of vancomycin, penicillin, and gentamicin. Antimirob Agents Chemother. 1991;35:776\u20139.","journal-title":"Antimirob Agents Chemother"},{"key":"7122_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1086\/321815","volume":"33","author":"HS Gold","year":"2001","unstructured":"Gold HS. Vancomycin-resistant Enterococci: mechanisms and clinical observations. Clin Infect Dis. 2001;33:210\u20139.","journal-title":"Clin Infect Dis"},{"key":"7122_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrmicro727","volume":"1","author":"C Walsh","year":"2003","unstructured":"Walsh C. Where will new antibiotics come from? Nat Rev Microbiol. 2003;1:65\u201370.","journal-title":"Nat Rev Microbiol"},{"key":"7122_CR11","unstructured":"WHO team (Antimicrobial Resistance Division). Antimicrobial resistance: global report on surveillance. WHO: Geneva; 2014. https:\/\/www.who.int\/publications\/i\/item\/9789241564748."},{"key":"7122_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature17042","volume":"529","author":"ED Brown","year":"2016","unstructured":"Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature. 2016;529:336\u201343.","journal-title":"Nature"},{"key":"7122_CR13","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1002\/chem.201703694","volume":"24","author":"R Barnett","year":"2018","unstructured":"Barnett R, Stallforth P. Natural products from social amoebae. Chem Eur J. 2018;24:4202\u201314.","journal-title":"Chem Eur J"},{"key":"7122_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/cells8010006","volume":"8","author":"Y Kubohara","year":"2019","unstructured":"Kubohara Y, Kikuchi H. Dictyostelium: an important source of structural and functional diversity in drug discovery. Cells. 2019;8:6.","journal-title":"Cells"},{"key":"7122_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/328811a0","volume":"328","author":"HR Morris","year":"1987","unstructured":"Morris HR, Taylor GW, Masento MS, Jermyn KA, Kay RR. Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum. Nature. 1987;328:811\u20134.","journal-title":"Nature"},{"key":"7122_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1042\/bj2490903","volume":"249","author":"HR Morris","year":"1988","unstructured":"Morris HR, Masento MS, Taylor GW, Jermyn KA, Kay RR. Structure elucidation of two differentiation inducing factors (DIF-2 and DIF-3) from the cellular slime mould Dictyostelium discoideum. Biochem J. 1988;249:903\u20136.","journal-title":"Biochem J"},{"key":"7122_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/biom9050163","volume":"9","author":"Y Kubohara","year":"2019","unstructured":"Kubohara Y, Shiratsuchi Y, Ishigaki H, Takahashi K, Oshima Y, Kikuchi H. Antimicrobial activities of Dictyostelium differentiation-inducing factors and their derivatives. Biomolecules. 2019;9:163.","journal-title":"Biomolecules"},{"key":"7122_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/0004563215593561","volume":"53","author":"G Weaving","year":"2016","unstructured":"Weaving G, Batstone GF, Jones RG. Age and sex variation in serum albumin concentration: an observational study. Ann Clin Biochem. 2016;53:106\u201311.","journal-title":"Ann Clin Biochem"},{"key":"7122_CR19","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1056\/NEJM196911202812109","volume":"281","author":"CM Kunin","year":"1969","unstructured":"Kunin CM. Drugs, receptors and serum protein binding. N Engl J Med. 1969;281:1188\u20139.","journal-title":"N Engl J Med"},{"key":"7122_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.me.27.020176.001443","volume":"27","author":"WA Craig","year":"1976","unstructured":"Craig WA, Kunin CM. Significance of serum protein and tissue binding of antimicrobial agents. Annu Rev Med. 1976;27:287\u2013300.","journal-title":"Annu Rev Med"},{"key":"7122_CR21","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/jac\/dkm078","volume":"59","author":"F Cafini","year":"2007","unstructured":"Cafini F, Aguilar L, Gonz\u00e1lez N, Gim\u00e9nez MJ, Torrico M, Alou L, Sevillano D, Vallejo P, Prieto J. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. J Antimicrob Chemother. 2007;59:1185\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"7122_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijantimicag.2009.09.021","volume":"35","author":"M Torrico","year":"2010","unstructured":"Torrico M, Gim\u00e9nez MJ, Gonz\u00e1lez N, Alou L, Sevillano D, Cafini F, Prieto J, Cleeland R, Aguilar L. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1\u20132 \u03bcg\/mL. Int J Antimicrob Agents. 2010;35:131\u20137.","journal-title":"Int J Antimicrob Agents"},{"key":"7122_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.bcp.2005.06.002","volume":"70","author":"N Gokan","year":"2005","unstructured":"Gokan N, Kikuchi H, Nakamura K, Oshima Y, Hosaka K, Kubohara Y. Structural requirements of Dictyostelium differentiation-inducing factors for their stalk-cell-inducing activity in Dictyostelium cells and anti-proliferative activity in K562 human leukemic cells. Biochem Pharmacol. 2005;70:676\u201385.","journal-title":"Biochem Pharmacol"},{"key":"7122_CR24","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bbrc.2010.04.098","volume":"396","author":"Y Kubohara","year":"2010","unstructured":"Kubohara Y, Kikuchi H, Nakamura K, Matsuo Y, Oshima Y. Preparation of an antibody that recognizes and neutralizes Dictyostelium differentiation-inducing factor-1. Biochem Biophys Res Commun. 2010;396:364\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"7122_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1242\/bio.20146585","volume":"3","author":"Y Kubohara","year":"2014","unstructured":"Kubohara Y, Kikuchi H, Matsuo Y, Oshima Y, Homma Y. Properties of a non-bioactive fluorescent derivative of differentiation-inducing factor-3, an anti-tumor agent found in Dictyostelium discoideum. Biol Open. 2014;3:289\u201396.","journal-title":"Biol Open"},{"key":"7122_CR26","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1128\/AAC.00124-14","volume":"58","author":"CT Mascio","year":"2014","unstructured":"Mascio CT, Chesnel L, Thorne G, Silverman JA. Surotomycin demonstrates low in vitro frequency of resistance and rapid bactericidal activity in Clostridium difficile, Enterococcus faecalis, and Enterococcus faecium. Antimicrob Agents Chemother. 2014;58:3976\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"7122_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/jac\/dkab069","volume":"76","author":"X Casta\u00f1eda","year":"2021","unstructured":"Casta\u00f1eda X, Garc\u00eda-De-la-M\u00e0ria C, Gasch O, Peric\u00e0s JM, Soy D, Ca\u00f1as-Pacheco MA, Falces C, Garc\u00eda-Gonz\u00e1lez J, Hern\u00e1ndez-Meneses M, Vidal B, Almela M, Quintana E, Tolosana JM, Fuster D, Llopis J, Dahl A, Moreno A, Marco F, Mir\u00f3 JM, Hospital Cl\u00ednic Endocarditis Study Group. Effectiveness of vancomycin plus cloxacillin compared with vancomycin, cloxacillin and daptomycin single therapies in the treatment of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in a rabbit model of experimental endocarditis. J Antimicrob Chemother. 2021;76:1539\u201346.","journal-title":"J Antimicrob Chemother"},{"key":"7122_CR28","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrd.2018.46","volume":"17","author":"J Rautio","year":"2018","unstructured":"Rautio J, Meanwell NA, Di L, Hageman MJ. The expanding role of prodrugs in contemporary drug design and development. Nat Rev Drug Discov. 2018;17:559\u201387.","journal-title":"Nat Rev Drug Discov"},{"key":"7122_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.202301169","volume":"20","author":"A Husain","year":"2023","unstructured":"Husain A, Monga J, Narwal S, Singh G, Rashid M, Afzal O, Alatawi A, Almadani NM. Prodrug rewards in medicinal chemistry: an advance and challenges approach for drug designing. Chem Biodivers. 2023;20: e202301169.","journal-title":"Chem Biodivers"},{"issue":"Suppl","key":"7122_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1242\/dev.107.Supplement.81","volume":"107","author":"RR Kay","year":"1989","unstructured":"Kay RR, Berks M, Traynor D. Morphogen hunting in Dictyostelium discoideum. Development. 1989;107(Suppl):81\u201390.","journal-title":"Development"},{"key":"7122_CR31","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1006\/scdb.1999.0341","volume":"10","author":"RR Kay","year":"1999","unstructured":"Kay RR, Flatman P, Thompson CRL. DIF signalling and cell fate. Seminar Cell Develop Biol. 1999;10:577\u201385.","journal-title":"Seminar Cell Develop Biol"},{"key":"7122_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0012-1606(90)90066-R","volume":"140","author":"B Wurster","year":"1990","unstructured":"Wurster B, Kay RR. New roles for DIF? Effects on early development in Dictyostelium. Dev Biol. 1990;140:189\u201395.","journal-title":"Dev Biol"},{"key":"7122_CR33","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1006\/bbrc.1995.1438","volume":"208","author":"K Asahi","year":"1995","unstructured":"Asahi K, Sakurai A, Takahashi N, Kubohara Y, Okamoto K, Tanaka Y. DIF-1, morphogen of Dictyostelium discoideum, induces the erythroid differentiation in murine and human leukemia cells. Biochem Biophys Res Commun. 1995;208:1036\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"7122_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1006\/bbrc.1997.6964","volume":"236","author":"Y Kubohara","year":"1997","unstructured":"Kubohara Y. DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60. Biochem Biophys Res Commun. 1997;236:418\u201322.","journal-title":"Biochem Biophys Res Commun"},{"key":"7122_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0014-2999(99)00548-8","volume":"381","author":"Y Kubohara","year":"1999","unstructured":"Kubohara Y. Effects of differentiation-inducing factors (DIFs) of Dictyostelium discoideum on the human leukemia K562 cells: DIF-3 is the most potent anti-leukemic agent. Eur J Pharmacol. 1999;381:57\u201362.","journal-title":"Eur J Pharmacol"},{"key":"7122_CR36","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/sj.onc.1206109","volume":"22","author":"M Kanai","year":"2003","unstructured":"Kanai M, Konda Y, Nakajima T, Izumi Y, Nanakin A, Kanda N, Kubohara Y, Chiba T. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK dependent pathway. Oncogene. 2003;22:548\u201354.","journal-title":"Oncogene"},{"key":"7122_CR37","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.1074\/jbc.M205768200","volume":"278","author":"F Takahashi-Yanaga","year":"2003","unstructured":"Takahashi-Yanaga F, Taba Y, Miwa Y, Kubohara Y, Watanabe Y, Hirata M, Morimoto S, Sasaguri T. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3\u03b2 and degrades cyclin D1 in mammalian cells. J Biol Chem. 2003;278:9663\u201370.","journal-title":"J Biol Chem"},{"key":"7122_CR38","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1111\/j.1742-4658.2007.05872.x","volume":"274","author":"W Omata","year":"2007","unstructured":"Omata W, Shibata H, Nagasawa M, Kojima I, Kikuchi H, Oshima Y, Hosaka K, Kubohara Y. Dictyostelium differentiation-inducing factor-1 induces glucose transporter 1 translocation and promotes glucose uptake in mammalian cells. FEBS J. 2007;274:3392\u2013404.","journal-title":"FEBS J"},{"key":"7122_CR39","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.lfs.2009.07.008","volume":"85","author":"K Takahashi","year":"2009","unstructured":"Takahashi K, Murakami M, Hosaka K, Kikuchi H, Oshima Y, Kubohara Y. Regulation of IL-2 production in Jurkat cells by Dictyostelium-derived factors. Life Sci. 2009;85:438\u201343.","journal-title":"Life Sci"},{"key":"7122_CR40","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.lfs.2011.01.004","volume":"88","author":"K Takahashi","year":"2011","unstructured":"Takahashi K, Murakami M, Kikuchi H, Oshima Y, Kubohara Y. Derivatives of Dictyostelium differentiation-inducing factors promote mitogen-activated IL-2 production via AP-1 in Jurkat cells. Life Sci. 2011;88:480\u20135.","journal-title":"Life Sci"},{"key":"7122_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072118","volume":"8","author":"Y Kubohara","year":"2013","unstructured":"Kubohara Y, Kikuchi H, Matsuo Y, Oshima Y, Homma Y. Mitochondria are the target organelle of differentiation-inducing factor-3, an anti-tumor agent isolated from Dictyostelium discoideum. PLoS ONE. 2013;8: e72118.","journal-title":"PLoS ONE"},{"key":"7122_CR42","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.bcp.2013.03.007","volume":"85","author":"J Nakajima-Shimada","year":"2013","unstructured":"Nakajima-Shimada J, Hatabu T, Hosoi Y, Onizuka Y, Kikuchi H, Oshima Y, Kubohara Y. Derivatives of Dictyostelium discoideum differentiation-inducing factor-3 suppress the activities of Trypanosoma cruzi in vitro and in vivo. Biochem Pharmacol. 2013;85:1603\u201310.","journal-title":"Biochem Pharmacol"},{"key":"7122_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jphs.2015.03.005","volume":"127","author":"N Kubokura","year":"2015","unstructured":"Kubokura N, Takahashi-Yanaga F, Arioka M, Yoshihara T, Igawa K, Tomooka K, Morimoto S, Nakatsu Y, Tsuzuki T, Nakabeppu Y, Matsumoto T, Kitazono T, Sasaguri T. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo. J Pharmacol Sci. 2015;127:446\u201355.","journal-title":"J Pharmacol Sci"},{"key":"7122_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bcp.2017.05.004","volume":"138","author":"M Arioka","year":"2017","unstructured":"Arioka M, Takahashi-Yanaga F, Kubo M, Igawa K, Tomooka K, Sasaguri T. Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion. Biochem Pharmacol. 2017;138:31\u201348.","journal-title":"Biochem Pharmacol"},{"key":"7122_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/biom9070256","volume":"9","author":"K Totsuka","year":"2019","unstructured":"Totsuka K, Makioka Y, Iizumi K, Takahashi K, Oshima Y, Kikuchi H, Kubohara Y. Halogen-substituted derivatives of Dictyostelium differentiation-inducing factor-1 suppress serum-induced cell migration of human breast cancer MDA-MB-231 cells in vitro. Biomolecules. 2019;9:256.","journal-title":"Biomolecules"},{"key":"7122_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114834","volume":"194","author":"T Mita","year":"2021","unstructured":"Mita T, Hirai M, Maki Y, Nahar S, Ikeda M, Yoshida N, Oshima Y, Kikuchi H, Kubohara Y. Derivatives of Dictyostelium differentiation-inducing factors suppress the growth of Plasmodium parasites in vitro and in vivo. Biochem Pharmacol. 2021;194: 114834.","journal-title":"Biochem Pharmacol"},{"key":"7122_CR47","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3390\/ijms25031889","volume":"25","author":"Y Kubohara","year":"2024","unstructured":"Kubohara Y, Fukunaga Y, Shigenaga A, Kikuchi H. Dictyostelium differentiation-inducing factor 1 promotes glucose uptake via direct inhibition of mitochondrial malate dehydrogenase in mouse 3T3-L1 cells. Int J Mol Sci. 2024;25:1889.","journal-title":"Int J Mol Sci"},{"key":"7122_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116243","volume":"225","author":"N Yoshida","year":"2024","unstructured":"Yoshida N, Kikuchi H, Hirai M, Balikagala B, Anywar DA, Taka H, Kaga N, Miura Y, Fukuda N, Odongo-Aginya EI, Kubohara Y, Mita T. A longer-chain acylated derivative of Dictyostelium differentiation-inducing factor-1 enhances the antimalarial activity against Plasmodium parasites. Biochem Pharmacol. 2024;225: 116243.","journal-title":"Biochem Pharmacol"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07122-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T03:20:56Z","timestamp":1738120856000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07122-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7122"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07122-5","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Patent related to this article were issued on February 15, 2019 (no. 6478378) in Japan. Juntendo University holds the patent; YK and HK are the inventors of the patent. KT, TN, HI, YM, and AT declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40"}}